Advair Diskus Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Alerts
• Clinical Trials
• Forums

Clinical Endpoint Bioequivalence Study for Fluticasone Propionate and Salmeterol Xinafoate
Condition:   AsthmaInterventions:   Drug: Fluticasone / Salmeterol;   Drug: Placebo;   Drug: Advair Diskus 100/50Sponsors:   Roxane Laboratories;   Vectura LimitedCompleted - verified January 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 5, 2016 Category: Research Source Type: clinical trials